AMI following Coronary Artery Dissection: Higher Mortality?

Though rare, spontaneous coronary artery dissection (SCAD) might lead to MI, most commonly affecting young middle aged women. 

Disección coronaria espontánea: ¿Hay diferencias entre hombres y mujeres?

In these cases, the angiographic image will present a characteristic double lumen, and an intramural hematoma in the coronary artery wall.

Normally, it will be treated medically. However, a small number of cases presenting STEMI will require primary percutaneous coronary intervention (PCI), which tend to be complex and are associated to dissection progression during procedure. Whether this involves higher mortality compared against PCI on non-SCAD patients presenting STEMI remains to be determined.

The study looked at 65,957 STEMI patients undergoing primary PCI between January 2016 and December 2020 in hospitals across Spain. 315 of these patients (0.48%) presented SCAD.

Even though the groups were similar, SCAD patients were younger, mostly women, hypertensive and with a history of MI. There were no differences in the rest of risk factors or the prevalence of cardiac failure, cardiorespiratory fitness or cardiogenic shock.  

Read also: ESC 2023 | Anticoagulation After Primary PCI in STEMI Patients.

Mortality was comparable in both groups (5.7% vs. 4.8%; P = 0.464), but hospital stay was longer among SCAD patients. Mortality was associated to complications driven by MI and cardiogenic shock. After adjusting for variables, there were no differences in terms of mortality (5.3% vs. 5.3% P=0.5). Also, patients were matched using propensity score, leaving 315 patients in both groups, with no differences in mortality (5.7% vs. 5.7% P=0.99).

At 30 days, there were no differences in hospital readmission (3% vs. 3.3% P=0.99 for SCAD and atherosclerosis driven STEMI respectively). This remained constant after adjusting for risk and propensity score matching. 

Conclusion

To sum up, primary PCI in SCAD driven STEMI patients, when indicated, presents similar mortality and comparable readmission rates at 30 days compared to non-SCAD atherosclerosis driven STEMI patients undergoing the same procedure. These findings support the value of primary PCI in this select group of patients. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Primary Percutaneous Coronary Intervention in Patients With Spontaneous Coronary Artery Dissection vs Coronary Artery Disease.

Reference: Fernando Alfonso, et al. J Am Coll Cardiol Intv 2023;16:1860–1869.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...